Company Research Report: Orpyx Medical Technologies Inc.

Company Overview

Name

Orpyx Medical Technologies Inc.

Mission

Orpyx is dedicated to extending the healthspan for individuals living with diabetes through personalized remote care solutions.

Founding Details

Founded by: No information is available.

Year of Establishment: No information is available.

Key People

Dr. Breanne Everett - CEO and Co-Founder

Denis Brisson - Chief Operations Officer (COO)

Marcel Groenland - Vice President, Operations

Justine Jones - Senior Vice President, Commercialization

Karen Smith - Vice President, Marketing

Travis Stevens - Senior Vice President, Research and Development

Torin Taerum - Senior Vice President, Software and Data Science

Sharilyn Weisbeck - Vice President, Finance

Headquarters

No information is available.

Number of Employees

No information is available.

Revenue

No information is available.

Known For

Orpyx is renowned for its innovative technological solutions aimed at preventing diabetic foot ulcers (DFUs) and extending the healthspan of people with diabetes through advanced remote monitoring systems.

Products

Orpyx SI® Sensory Insoles

Description: The Orpyx SI® Sensory Insoles are advanced devices designed to prevent diabetic foot ulcers by continuously monitoring critical foot health indicators such as plantar pressure, temperature, step count, and adherence for patients with peripheral neuropathy.

Key Features:

Monitoring Capabilities: Provides real-time tracking of plantar pressure, step count, and temperature.

Data-Driven Patient Care: Utilizes an analytics-driven approach to transform patient data into actionable insights.

Remote Monitoring and Engagement: Enables personalized support and clinical escalation through remote patient monitoring.

Wireless Charging and Extended Battery Life: Recently upgraded to include step count measurements and wireless charging, with an extended battery life requiring charging only once a week.

Connectivity: Comes with a cellular-connected digital display, offering seamless data integration.

Recent Developments

Funding and Investment

$20 Million Investment: Orpyx secured $20 million in growth capital led by Perceptive Advisors, which will support the company’s mission of enhancing diabetes healthspan and commercial expansion.

Awards and Recognition

JWC/WUWHS Awards: Orpyx and its CEO Dr. Breanne Everett received top honors at the JWC/WUWHS Awards. The Orpyx SI Sensory Insoles were recognized in the “Most Innovative Dressing or Device” category, while Dr. Everett received the award for “Innovations in Diabetic Foot Care."

Partnerships

Siksika Health Services Collaboration: Orpyx, along with Siksika Health Services and GMAK Consulting, expanded a pilot program aimed at improving foot health and preventing diabetic foot ulcers among the Siksika Nation.

Product Launches

Orpyx SI® Flex Sensory Insoles & Diabetes Healthspan Extension: Launched new models and care frameworks aimed at enhancing existing product capabilities and extending patient health outcomes.

New Features

Product Enhancements: Recent updates to the Orpyx SI® Sensory Insoles include step count measurements, state-of-the-art sensor technology, and wireless connectivity features to improve usability and patient engagement.

Conclusion

Orpyx Medical Technologies Inc. continues to make significant strides in the diabetes care industry with its cutting-edge products and strategic initiatives focused on enhancing patient outcomes. With ongoing investments and collaborations, the company strengthens its position as a leader in diabetic foot ulcer prevention and healthspan extension for people with diabetes.